Premium
ChromaDex Corporation (CDXC)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship in... ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors. Show more
ChromaDex Corp. (NASDAQ:CDXC) proudly announces its inclusion on the Inc. 2024 Best in Business list in the Health Products category. Inc.’s annual Best in Business Awards celebrate the...
The gold standard in NAD+ supplementation, Niagen® is a key ingredient for supporting cellular health and promoting healthy aging in Longevity.Technology’s new supplement ChromaDex Corp. (NASDAQ:...
National rollout provides enhanced accessibility to Niagen IV, a significant advancement in NAD+ IV therapy ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine...
Total net sales of $25.6 million, up $6.1 million or 31% year-over-year, gross margin of 63.5% and record net income and adjusted EBITDA of $1.9 million and $2.9 million, respectively, for the...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.8756 | -11.5277265785 | 7.5956 | 7.9738 | 6.625 | 715465 | 7.25565316 | CS |
| 4 | 0.04 | 0.59880239521 | 6.68 | 7.9738 | 6.22 | 969606 | 7.25278538 | CS |
| 12 | 3.22 | 92 | 3.5 | 7.9738 | 3.18 | 1254363 | 5.95071518 | CS |
| 26 | 3.82 | 131.724137931 | 2.9 | 7.9738 | 2.305 | 788912 | 5.1600507 | CS |
| 52 | 5.3 | 373.23943662 | 1.42 | 7.9738 | 1.32 | 509739 | 4.68679916 | CS |
| 156 | 2.36 | 54.128440367 | 4.36 | 7.9738 | 1.15 | 346218 | 3.35739661 | CS |
| 260 | 2.93 | 77.308707124 | 3.79 | 23.66 | 1.15 | 541223 | 8.08374202 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
